Clinical trial

Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis

NCT07497282

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-03-26

PhasePHASE2

Study timeline

Study start (estimated)2026-03-26Date precision: day

Registry last updated2026-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

venlafaxine extended-release (XR)DRUG

Standard conventional Rheumatoid Arthritis TherapyOTHER

Sponsors & collaborators

Ain Shams Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07497282 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.